TELOMERE BIOLOGY DISORDERS
Clinical trials for TELOMERE BIOLOGY DISORDERS explained in plain language.
Never miss a new study
Get alerted when new TELOMERE BIOLOGY DISORDERS trials appear
Sign up with your email to follow new studies for TELOMERE BIOLOGY DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New transplant method aims to cut immune suppression in bone marrow failure patients
Disease control Recruiting nowThis study tests a special stem cell transplant that removes certain immune cells to lower the risk of graft-versus-host disease (GVHD) and reduce the need for long-term immune-suppressing drugs. It is for people with inherited bone marrow failure disorders like Fanconi anemia. T…
Matched conditions: TELOMERE BIOLOGY DISORDERS
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated May 17, 2026 01:52 UTC
-
New drug combo aims to slow rare Aging-Like diseases
Disease control Recruiting nowThis early-stage trial tests whether a combination of two natural substances (deoxycytidine and deoxythymidine) is safe for people with telomere biology disorders—rare conditions that cause premature aging, bone marrow failure, and lung disease. Up to 36 participants aged 1 to 70…
Matched conditions: TELOMERE BIOLOGY DISORDERS
Phase: PHASE1 • Sponsor: Suneet Agarwal • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
20-Year study to track rare bone marrow diseases
Knowledge-focused Recruiting nowThis study follows 1,000 people aged 2 and older with bone marrow failure diseases (like severe aplastic anemia) for up to 20 years. Researchers want to understand how these diseases and their treatments affect the body over time. Participants have regular check-ups, blood tests,…
Matched conditions: TELOMERE BIOLOGY DISORDERS
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated May 17, 2026 01:49 UTC